Clinical Trial Update: A Study of a Personalized Neoantigen Cancer Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a personalized neoantigen cancer vaccine completed across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastroesophageal Adenocarcinoma
• Non-small Cell Lung Cancer
• Urothelial Carcinoma

Drugs mentioned

• Personalized Neoantigen Cancer Vaccine

Snippet

Sponsor: Gritstone bio, Inc. | Conditions: Non Small Cell Lung Cancer, Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED